Abstract: Provided herein is technology relating to tomato extracts and particularly, but not exclusively to preparing and using tomato extracts as an anti-hypertensive agent to modulate blood pressure.

Abstract: The present invention is directed to methods for collecting and processing autografts, processed autografts, kits for collecting and transporting autografts, and tools for preparing autografts. It is also directed to autologous bone grafts, and methods of preparing them.

Abstract: A composition for optic nerve cell protection, for preventing or treating glaucoma, for suppressing retinal ganglion cell death, or for delaying a progression of visual acuity loss of human contains at least one selected from the group consisting of products obtained by steaming and drying wheat, defatted wheat germ, defatted rice germ, defatted soybean, fermented grape, hesperidin, lactic acid bacterium Lactobacillus salivarius, wild grape, Tamarind, Haskap, pomegranate seeds, licorice powder, and cinnamon powder.

Abstract: Disclosed is a method for treating dry or erythemic skin in a subject in need thereof, the method comprising topically applying to the skin a composition that includes effective amounts of an extract from Echinacea purpurea and an extract from Silybum marianum, wherein topical application of the composition activates human cannabinoid receptor type 2 and inhibits fatty acid amide hydrolase activity in the skin and treats the skin.

Abstract: A transplant product made from human amniotic fluid has a supernatant from filtered and centrifuged amniotic fluid, the amniotic fluid when recovered aseptically having a clear, translucent to slightly pink or tan color. The supernatant had been taken from the amniotic fluid which had been passed through a 170 to 260 micron blood filter, then centrifuged for 5 minutes or more at 400 g and thereafter the supernatant was separated from a pellet of debris, leaving the biochemical properties intact, wherein the supernatant is cryofrozen in sized cryovials having 0.25 to 2.0 ml of the supernatant at a temperature of ?65 degrees or less prior to use and the transplant products method of use. The transplant product contains cellular material, cell fragments, proteins and growth factors maintaining the biochemical properties and is non-immunogenic while having particles up to 170 microns being passable through a 30 gauge syringe for injection.

Abstract: A method for treating the skin of a subject in need thereof is disclosed. The method includes topically applying to the skin of the subject a cosmetic composition that includes an effective amount of an aqueous, alcoholic, or aqueous-alcoholic extract of Silybum marianum and an aqueous, alcoholic, or aqueous-alcoholic extract of Momordica grosvenori fruit.

Abstract: A method for increasing the expressions of TPH1 gene, DDC gene and/or AANAT gene is provided. The method comprises administering to a subject in need a composition, wherein the composition comprises an effective amount of a banana peel extract. The method is effective in treating, preventing or adjusting diseases or physiological functions related to TPH1, DDC and/or AANAT genes.

Abstract: An apparatus and a method for plant extraction are disclosed. The apparatus of the present invention comprises an extraction module, a separating module and a reservoir. The method essentially includes plant material preparing, decarboxylating, active components extracting and separating. By using liquid tetrafluoroethane as the solvent in the apparatus of the present invention, the active components of the plant material are efficiently extracted under low pressure extraction and high pressure extraction conditions.

Abstract: A dietary supplement including monacolin K, phytosterols, policosanols, resveratrol, trimethylglycine and coenzyme Q10 is provided.

Abstract: The method of preparing biogenic silver nanoparticles includes preparing an aqueous plant extract by boiling cut leaves of Alternanthera bettzickiana (Regel) G. Nicholson in distilled water, retaining the aqueous extract. The aqueous plant extracts were mixed with aqueous solutions of silver ions derived from different silver salt precursors (e.g., silver nitrate, silver sulfate, etc.). The resulting biogenic silver nanoparticles exhibit antimicrobial activity against various strains of gram-positive and gram-negative organisms, including some strains of drug-resistant microorganisms. The biogenic silver nanoparticles also exhibit anticancer activity against certain human cancer cell lines. Surprisingly, biogenic silver nanoparticles prepared from nitrate precursor exhibited greater anticancer activity than nanoparticles from sulfate precursor, while biogenic silver nanoparticles prepared from sulfate precursor exhibited greater antibacterial activity than nanoparticles from nitrate precursor.

Abstract: The present invention relates to methods of preparing loline alkaloids, compositions comprising loline alkaloids including pesticidal compositions, and uses of the compositions including uses as biological control agents. Methods for the control of pests, including plant or animal pests, and for the enhancement of plant growth or reproduction, and treatment and prevention of insect infection and infestation, for example in plants and animals, are also provided.

Abstract: A method for producing an artificial sebum film is provided with in raw material component and relative ratio, 78.4%-2% of triglyceride, 1%-15% of wax and ester, 20%-35% of squalane, 0.1%-7% of free fatty acid, 0.1%-6% of phospholipid, 0.1%-10% of cholesterol ester, 0.1%-10% of cholesterol, 0.1%-10% of antioxidant and 0.1%-5% of cellular activity regulator. The invention modifies the proportion of raw material composition of the artificial sebum film to reduce the negative effect generated by oxidation, and increase the proportion of squalane, so that the skin under high pollution can restore to the normal equilibrium state. Further, antioxidants and cellular active regulators are added to prolong the oxidation time of artificial sebum film and replenish the adenosine triphosphate in the cells.

Abstract: Products, processes, compositions, kits, and methods are provided for cartilage-derived implants. The implants can exhibit resistance to enzyme (e.g., collagenase, protease, etc.) digestion compared to the source tissue from which they were derived while still having one or more mechanical properties comparable to the source tissue from which they were derived. The implants can also have a plurality of molecular bridges between molecules of the cartilaginous material. The molecular bridges can connect one or more collagen fibrils and/or/with one or more glycosaminoglycans. The implants can also be treated with cationic detergent, packaged and sterilized with or without additional components, and surgically implanted into subjects.

Abstract: Disclosed are shenlingbaizhu granules and a preparation method thereof, wherein the shenlingbaizhu granules comprise an extract of raw material medicines and excipients, the raw material medicines being: 400 parts by weight of ginseng, 400 parts by weight of tuckahoe, 400 parts by weight of Rhizoma atractylodis macrocephalae stir-fried with bran, 400 parts by weight of yam, 300 parts by weight of fried white hyacinth bean, 200 parts by weight of lotus seed, 200 parts by weight of coix seed stir-fried with bran, 200 parts by weight of Fructus amomi, 200 parts by weight of Platycodon grandiflorum, and 400 parts by weight of licorice, wherein the excipients comprise citric acid, stevioside and lactose, and the granules are dispersed by adding an appropriate amount of water and then obtaining a clear solution.

Abstract: A composition that includes at least one target supplement and at least one rehydration formulation is described. When the at least one target supplement is ingested as part of the composition, the bioavailability of at least one target supplement is enhanced as compared to when it is ingested separate from the composition. The at least one target supplement is absorbed more quickly and in a greater amount when it is ingested as part of the composition than when it is ingested separate from the composition. The composition also hydrates a subject more quickly.

Abstract: The invention provides a pain therapy cream comprising an anhydrous topical delivery formulation for percutaneous absorption comprising an anhydrous carrier medium, a chemical exfoliant, a penetration enhancer, and one or more pain killing agent selected from the group consisting of an analgesic, anesthetic, anti-inflammatory, or antipruritic agent, a phytochemical and other painkilling active ingredients, and methods of using the pain therapy cream.

Abstract: Processes for preparing antioxidant-rich compositions, for example from coffee cherries, are disclosed. These processes can involve promptly contacting de-beaned coffee cherries with a preservative coating, and optionally storing under refrigerated conditions, prior to the preparation of an extract or powder.

Abstract: The present invention relates to a steeping process for reducing the phytate in kernels of cereals and/or pulses using endogenous phythase. The kernels are steeped in water whilst avoiding germination and then dried. The steeped kernels and/or flour made therefrom are used in food, feed, pet-food, and/or cosmetics.

Abstract: A so-called molecular-targeted drug acting on a signal transduction pathway in a cell has been developed. However, a side effect of the molecular-targeted drug is not negligible for a patient. Thus, there has been a demand for a substance that exhibits a significant growth inhibitory effect on a cancer cell with fewer side effects as a health food and a pharmaceutical composition. It has been found that a hexane extract fraction of a watermelon sprout has an effect of specifically inhibiting the cell growth of the cancer cell and such an effect is primarily caused by phytol and lutein. A processed food and pharmaceutical composition having these substances as main components can exert an anticancer action without causing side effects.

Abstract: Some embodiments are directed to a cosmetic composition including at least one extract of Jania rubens and at least one extract of everlasting. Some embodiments are also directed to the cosmetic use of a composition including at least one extract of Jania rubens and at least one extract of everlasting. Some embodiments are also directed to a non-therapeutic anti-ageing cosmetic treatment and/or the protection of the skin against external attacks, using a cosmetic composition including at least one extract of Jania rubens and at least one extract of everlasting. Some embodiments particularly apply to the cosmetic and/or dermatological fields.